Navigation Links
Tissue engineering methods earn funding to heal little hearts
Date:2/18/2011

HOUSTON (Feb. 18, 2011) -Texas Children's Hospital in Houston announces that a researcher in its Pediatric Cardiac Bioengineering Laboratory has earned a National Science Foundation Early Career Development (CAREER) Award for his work in studying the causes of congenital heart disease, heart defects, and the development of tissue engineering therapies using stem cells derived from human amniotic fluid. The award comes with new funding of $450,000 to be spread over a five-year period.

Jeffrey Jacot, Ph.D, director of the Pediatric Cardiac Bioengineering Laboratory at the Congenital Heart Surgery Service at Texas Children's Hospital and an assistant professor of bioengineering at Rice University, submitted work based on two years of previously published studies on the effects of substrate stiffness on maturing heart cells, the mechanical environment of cardiovascular tissues, and the development of heart tissue grown from stem cells taken from the amniotic fluid of patients' mothers. His work with cardiac tissue stems from a 2009 grant from the Virginia and L.E. Simmons Family Foundation Collaborative Research Fund, which promotes research among Texas Medical Center scientists, engineers and doctors who might not otherwise work together.

"I am pleased to be part of the groundbreaking congenital heart research at Texas Children's Hospital," said Dr. Jacot. "We hope this work will lead to the development of living heart tissue that might work to 'patch' or reconstruct hearts with congenital defects."

As a principal investigator on several projects, Jacot works alongside surgeons and radiologists at Texas Children's Hospital and with cardiovascular research laboratories at Baylor College of Medicine (BCM) to establish a therapeutically feasible stem cell source and understand how to control growth of new cardiac tissue.

"Dr. Jacot is a talented and highly inventive young member of the biomedical engineering community whose detailed analysis and rationally designed experiments bring a unique approach to the study and treatment of congenital heart disease," said Charles D. Fraser Jr., M.D., surgeon-in-chief and chief of congenital heart surgery at Texas Children's Hospital and professor of surgery at BCM. "Because the regenerative cardiac therapies developed in his lab are grown from amniotic fluid-derived stem cells, they are genetically identical to the child and have potential to grow with the patient with minimal immune response."

Jacot's CAREER Award also includes an interactive exhibition and outreach program for elementary, middle and high school students to be developed in cooperation with the John P. McGovern Museum of Health and Medical Science (MMHM) in Houston. The educational component, which is intended to inspire and help guide the next generation of scientists and engineers, includes field trips and teacher workshops, as well as lectures and problem-based curriculum in systems physiology at Rice.


'/>"/>

Contact: Carol Wittman
cmwittma@texaschildrens.org
832-824-2040
Texas Children's Hospital
Source:Eurekalert

Related medicine news :

1. New study suggests stem cells sabotage their own DNA to produce new tissues
2. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
3. Step Up to Speak Up Events Use Spoken Word and African-American Greek Tradition of Stepping to Raise Awareness for Organ and Tissue Donation
4. CSMG Technologies, Inc. Engages New Team to Manage Live Tissue Connect, Inc.
5. Paired drugs kill precancerous colon polyps, spare normal tissue
6. Tissue engineers create a new way to assemble artificial tissues
7. Ultrasound could boost tissue implant success
8. Color-coded tracking method helps scientists analyze outcomes of newly transplanted tissue
9. Molecular Signatures in Post-Mortem Brain Tissue of Younger Individuals at High Risk for Alzheimer's Disease
10. Scholar calls for a new legal, ethical framework for research with human tissue specimens
11. New method of tissue banking makes gene analysis more practical for lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... , ... June 28, 2017 , ... Park Systems ... AFM Luncheon for all SEMICONWest attendees and Park customers on July 11, ... talks from Dr. Sang-il Park, Chairman & CEO of Park Systems, and Prof. ...
(Date:6/28/2017)... ... 28, 2017 , ... The Dianne Michael Insurance Agency, a ... area, is teaming up with the local chapter of the Ronald McDonald House ... nearby hospitals. , Ronald McDonald House of Greater Cincinnati, one of the many ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... for many of the health care industry’s hospitals and provider groups, has announced ... portal for select customers. Parasail Health is a San Francisco health-finance startup that ...
(Date:6/27/2017)... ... June 27, 2017 , ... Two residents from the Gardant-managed assisted living and ... designed to encourage lawmakers to protect Medicaid funding. , The video, which was produced ... the story of Chuck and Cathy Schwarz, a couple who is still able to ...
(Date:6/27/2017)... ... 2017 , ... Dr. Richard Amato, a respected periodontist in Monroe, ... Dental Implant Center of Connecticut. As part of the renovation, the cutting-edge practice added ... intended to improve patient comfort while making it possible for Dr. Amato to provide ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... and INDIANAPOLIS , June ... are living with diabetes. In a further effort to ... people affected by this condition, the International Diabetes Federation ... LLY ) have come together for the second phase ... and Systems programme (BRIDGES 2), reaffirming their commitment to ...
(Date:6/7/2017)... Inc., (Nasdaq: NVAX ) today announced that data ... RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) ... the journal Vaccine (the data contained ... The Company previously announced top line results from ... F Vaccine with the goal of protecting infants from RSV ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
Breaking Medicine Technology: